Viewing Study NCT06636188



Ignite Creation Date: 2024-10-25 @ 7:50 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06636188
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: None
First Post: 2024-10-03

Brief Title: A Chatbot to Reduce Physical and Psychological Distress of Patients With Head and Neck Cancer Undergoing Radiotherapy
Sponsor: None
Organization: None

Study Overview

Official Title: Novel Artificial Intelligence Patient Navigator Chatbot to Reduce Physical and Psychological Distress of Patients With Head and Neck Cancer Undergoing Radiotherapy A Randomized Controlled Trial
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer

The main question it aims to answer is How effective is the Digi-Coach chatbot in reducing physical and psychological distress

Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer

Participants will have access to the Digi-Coach chatbot during radiotherapy in addition to usual care The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot
Detailed Description: The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer

The main question it aims to answer is How effective is the Digi-Coach chatbot in reducing physical and psychological distress Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer

A single-blinded parallel randomized controlled trial RCT allocation ratio 11 will be conducted with baseline data collection at week 1 T0 and three follow-up timepoints at week 8 T1 week 12 T2 following radiotherapy commencement

Participants in the Treatment-As-Usual group will receive routine onsite nursing care in which the nurse discussed general knowledge of self-care behaviors regarding the management of radiotherapy-related side effects

Participants in the intervention group will have access to the Digi-Coach chatbot in addition to usual care The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None